Market Overview:
The global intravenous anesthetic market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of chronic diseases, increasing number of surgical procedures, and growing demand for minimally invasive surgeries. Based on type, the tetrazolium segment is expected to account for the largest share of the global intravenous anesthetic market in 2018. This segment is also projected to grow at the highest CAGR during the forecast period. Tetrazoliums are used as general anaesthetics and are known for their fast onset and short duration of action. They are also non-irritating and cause minimal cardiovascular depression. Based on application, hospital use is expected to account for the largest share of the global intravenous anesthetic market in 2018.
Product Definition:
Intravenous anesthetic is a type of anesthesia that is administered through a vein, as opposed to inhaled or injected anesthesia. Intravenous anesthetics are typically fast-acting and produce rapid onset of anesthesia. They are commonly used for procedures that require short-term general anesthesia, such as certain types of surgery.
Tetrazolium:
Tetrazolium is a chemical compound, which has six carbon atoms and one nitrogen atom. It is also known as N-tetrazolium and commonly found in nature as well as produced by the reaction of aziridine with nitric acid. Tetrazolium salts are used for the measurement of biological fluids such as urine, blood cells, gastric juices and sweat; in turn aiding clinicians to monitor renal function during anesthesia procedures along with monitoring body fluid balance.
Ketamine:
Ketamine is an injectable anesthetic that is most commonly used in Intravenous Anesthesia (IVA). It's mechanism of action and effects are similar to those of phencyclidine; however, it has a more predictable pharmacology. Ketamine’s half-life is around 3 hours which makes it ideal for IV administration.
Application Insights:
Based on application, the global intravenous anesthetic market is segmented into hospital use, clinic use, and others. The other applications include emergency room procedures and pain management clinics. IV sedation/anesthesia is widely used in pain management clinics for patients who require surgery but cannot have anesthesia due to medical conditions or drug allergies. In addition, increasing awareness among patients regarding their right to choose the type of anesthesia they prefer has led to a rise in IV sedation/anesthesia usage at outpatient surgical facilities as well as hospitals across the globe.
The hospital use segment dominated the overall industry with a share of over 60% in 2017 owing to its extensive usage during surgeries that require general anesthetic such as neurosurgeries.
Regional Analysis:
North America dominated the global intravenous anesthetic market in 2017. This can be attributed to factors such as increasing incidence of surgeries, rising number of ambulatory surgical centers, and growing adoption of minimally invasive surgeries. In addition, presence of key players in this region is also expected to drive growth during the forecast period. For instance, Pfizer Inc., manufacturer Tetrazepamidin North America has expanded its product portfolio by introducing Oxaparazine Hydrochloride Extended-Release Tablets (Oxyzolamide HCl) for Infusion Therapy).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rise in medical tourism and improving healthcare infrastructure along with economic development. Moreover, increase in prevalence of chronic diseases coupled with high demand for surgery related procedures are some other factors driving regional market growth during the estimated time frame.
Growth Factors:
- Increasing incidence of surgery and other medical procedures requiring anesthesia
- Growing demand for regional and local anesthesia over general anesthesia
- Rising number of anesthesiologists and other healthcare professionals trained in administering intravenous anesthetics
- Advances in drug delivery technology that make intravenous anesthetics more user-friendly
- Increased awareness among patients and healthcare providers about the benefits of using intravenous anesthetics
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravenous Anesthetic Market Research Report
By Type
Tetrazolium, Ketamine, Sodium Oxybate, Other
By Application
Hospital Use, Clinic Use, Other
By Companies
AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals, Mylan, Nhwa, Lunan, Hengrui
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Intravenous Anesthetic Market Report Segments:
The global Intravenous Anesthetic market is segmented on the basis of:
Types
Tetrazolium, Ketamine, Sodium Oxybate, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Use, Clinic Use, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Fresenius-Kabi
- BbVie Laboratories
- Baxter Healthcare
- Braun
- Maruishi
- Piramal Healthcare
- Hikma Pharmaceuticals
- Mylan
- Nhwa
- Lunan
- Hengrui
Highlights of The Intravenous Anesthetic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tetrazolium
- Ketamine
- Sodium Oxybate
- Other
- By Application:
- Hospital Use
- Clinic Use
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intravenous Anesthetic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intravenous anesthetic is a type of medication that numbs the area around a vein. This can be used to make surgery or other medical procedures less painful.
Some of the major players in the intravenous anesthetic market are AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals, Mylan, Nhwa, Lunan, Hengrui.
The intravenous anesthetic market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intravenous Anesthetic Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intravenous Anesthetic Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intravenous Anesthetic Market - Supply Chain
4.5. Global Intravenous Anesthetic Market Forecast
4.5.1. Intravenous Anesthetic Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intravenous Anesthetic Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intravenous Anesthetic Market Absolute $ Opportunity
5. Global Intravenous Anesthetic Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intravenous Anesthetic Market Size and Volume Forecast by Type
5.3.1. Tetrazolium
5.3.2. Ketamine
5.3.3. Sodium Oxybate
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intravenous Anesthetic Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intravenous Anesthetic Market Size and Volume Forecast by Application
6.3.1. Hospital Use
6.3.2. Clinic Use
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intravenous Anesthetic Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intravenous Anesthetic Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intravenous Anesthetic Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intravenous Anesthetic Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intravenous Anesthetic Demand Share Forecast, 2019-2026
9. North America Intravenous Anesthetic Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intravenous Anesthetic Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intravenous Anesthetic Market Size and Volume Forecast by Application
9.4.1. Hospital Use
9.4.2. Clinic Use
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intravenous Anesthetic Market Size and Volume Forecast by Type
9.7.1. Tetrazolium
9.7.2. Ketamine
9.7.3. Sodium Oxybate
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intravenous Anesthetic Demand Share Forecast, 2019-2026
10. Latin America Intravenous Anesthetic Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intravenous Anesthetic Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intravenous Anesthetic Market Size and Volume Forecast by Application
10.4.1. Hospital Use
10.4.2. Clinic Use
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intravenous Anesthetic Market Size and Volume Forecast by Type
10.7.1. Tetrazolium
10.7.2. Ketamine
10.7.3. Sodium Oxybate
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intravenous Anesthetic Demand Share Forecast, 2019-2026
11. Europe Intravenous Anesthetic Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intravenous Anesthetic Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intravenous Anesthetic Market Size and Volume Forecast by Application
11.4.1. Hospital Use
11.4.2. Clinic Use
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intravenous Anesthetic Market Size and Volume Forecast by Type
11.7.1. Tetrazolium
11.7.2. Ketamine
11.7.3. Sodium Oxybate
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
1.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intravenous Anesthetic Demand Share, 2019-2026
12. Asia Pacific Intravenous Anesthetic Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intravenous Anesthetic Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intravenous Anesthetic Market Size and Volume Forecast by Application
12.4.1. Hospital Use
12.4.2. Clinic Use
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intravenous Anesthetic Market Size and Volume Forecast by Type
12.7.1. Tetrazolium
12.7.2. Ketamine
12.7.3. Sodium Oxybate
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intravenous Anesthetic Demand Share, 2019-2026
13. Middle East & Africa Intravenous Anesthetic Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intravenous Anesthetic Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intravenous Anesthetic Market Size and Volume Forecast by Application
13.4.1. Hospital Use
13.4.2. Clinic Use
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intravenous Anesthetic Market Size and Volume Forecast by Type
13.7.1. Tetrazolium
13.7.2. Ketamine
13.7.3. Sodium Oxybate
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intravenous Anesthetic Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intravenous Anesthetic Market: Market Share Analysis
14.2. Intravenous Anesthetic Distributors and Customers
14.3. Intravenous Anesthetic Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Fresenius-Kabi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BbVie Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Baxter Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Braun
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Maruishi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Piramal Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hikma Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mylan
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nhwa
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lunan
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hengrui
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
